JENNIFER SAMAAN: Open Payments
NPI 1770183790 · HARRISON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 19 payments from 5 companies in 2025. Trend: 2023 $2,010 · 2024 $1,891 · 2025 $1,139
Food & beverage: $1,139
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $648 |
| Novo Nordisk Inc | 5 | $175 |
| GlaxoSmithKline, LLC. | 5 | $175 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Dexcom, Inc. | 1 | $21 |
Products named: JARDIANCE, Ozempic, AREXVY, LOKELMA, Dexcom G6 Transmitter, SHINGRIX, NUCALA, TRELEGY ELLIPTA.
Industry payments across NJ — which companies pay providers there.
